Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
CARLSBAD, Calif., May 08, 2017 -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its first quarter 2017 financial results on Thursday, May 11, 2017 after the market closes.
The Company will hold a conference call on Thursday, May 11, 2017 at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 556-5251 for domestic callers and (720) 545-0036 for international callers. The conference ID number is 19608962. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.alphatecspine.com.
A replay of the webcast will remain available on the Company’s website, www.alphatecspine.com, until the Company releases its second quarter 2017 financial results. In addition, a telephonic replay of the call will be available until May 18, 2017. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 19608962.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., through its wholly-owned subsidiary of Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve lives by delivering advancements in spinal fusion technologies. The Company markets products in the U.S. via independent sales agents and a direct sales force.
Additional information can be found at www.alphatecspine.com.
Investor/Media Contact: Nick Laudico or Zack Kubow The Ruth Group (646) 536-7000 [email protected] Company Contact: Jeff Black Executive Vice President and CFO Alphatec Holdings, Inc. (760) 431-9286
